<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Pharm Anal</journal-id><journal-id journal-id-type="iso-abbrev">J Pharm Anal</journal-id><journal-id journal-id-type="pmc-domain-id">3328</journal-id><journal-id journal-id-type="pmc-domain">jpa</journal-id><journal-title-group><journal-title>Journal of Pharmaceutical Analysis</journal-title></journal-title-group><issn pub-type="ppub">2095-1779</issn><issn pub-type="epub">2214-0883</issn><publisher><publisher-name>Xi'an Jiaotong University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5760807</article-id><article-id pub-id-type="pmcid-ver">PMC5760807.1</article-id><article-id pub-id-type="pmcaid">5760807</article-id><article-id pub-id-type="pmcaiid">5760807</article-id><article-id pub-id-type="pmid">29403709</article-id><article-id pub-id-type="doi">10.1016/j.jpha.2011.09.006</article-id><article-id pub-id-type="publisher-id">S2095-1779(11)00033-5</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Comparative pharmacokinetics of chlorogenic acid after oral administration in rats</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Qi</surname><given-names initials="W">Wei</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhao</surname><given-names initials="T">Ting</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="WW">Wen-Wen</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="GH">Guang-Hou</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yu</surname><given-names initials="H">Hua</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhao</surname><given-names initials="HX">Hai-Xiao</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="C">Chen</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="LX">Li-Xin</given-names></name><email>sunlixin67@yahoo.com</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff1"><label>a</label>School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China</aff><aff id="aff2"><label>b</label>Liaoning Institute of Pharmaceutical Industry, Shenyang 110015, China</aff><author-notes><corresp id="cor1"><label>*</label>Corresponding author. <email>sunlixin67@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>06</day><month>11</month><year>2011</year></pub-date><volume>1</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">304458</issue-id><fpage>270</fpage><lpage>274</lpage><history><date date-type="received"><day>27</day><month>6</month><year>2011</year></date><date date-type="accepted"><day>14</day><month>8</month><year>2011</year></date></history><pub-history><event event-type="pmc-release"><date><day>06</day><month>11</month><year>2011</year></date></event><event event-type="pmc-live"><date><day>05</day><month>02</month><year>2018</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-08-11 18:25:10.603"><day>11</day><month>08</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2011 Xi'an Jiaotong University</copyright-statement><copyright-year>2011</copyright-year><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract><p>The present study was aimed at the comparison of the pharmacokinetics of pure chlorogenic acid and extract of <italic toggle="yes">Solanum lyratum</italic> Thunb. The animals were allocated to two groups, and were administered chlorogenic acid or extract of <italic toggle="yes">S. lyratum</italic> Thunb. at a dose of 50.0&#160;mg/kg orally. Blood samples were collected up to 8&#160;h post-dosing. Plasma chlorogenic acid analyses were performed using an HPLC method with UV detector. The pharmacokinetic parameters were evaluated using non-compartmental assessment. Significant differences existed in the two groups for AUC<sub>0&#8722;<italic toggle="yes">t</italic></sub>, AUC<sub>0&#8722;&#8734;</sub> and CLz/F. The reliable HPLC method was successfully applied to the determination of chlorogenic acid in rat plasma at dosage of 50.0&#160;mg/kg.</p></abstract><kwd-group><title>Keywords</title><kwd><italic toggle="yes">Solanum lyratum</italic> Thunb</kwd><kwd>Chlorogenic acid</kwd><kwd>Pharmacokinetic</kwd><kwd>HPLC</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s0005"><label>1</label><title>Introduction</title><p id="p0005"><italic toggle="yes">Solanum lyratum</italic> Thunb (Solanaceae) is one of the most valued Chinese traditional medicines. It is well known as &#8220;<italic toggle="yes">Hedrba Solani Lyrati</italic>&#8221; in mainland of China, which has been used for regulating body immune function and ability <xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>. It was also reported to have anticancer activity <xref rid="bib5" ref-type="bibr">[5]</xref>. The plant is known to contain steroidal glucuronides, steroidal alkaloid glucosides, coumarin and phenolic acid, etc. <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib9" ref-type="bibr">[9]</xref>, <xref rid="bib10" ref-type="bibr">[10]</xref>.</p><p id="p0010">Chlorogenic acid (3-<italic toggle="yes">O</italic>-caffeoylquinic acid) is composed of quinic acid and caffeic acid. It is the major active component of <italic toggle="yes">S. lyratum</italic>, and its amount could reach up to 3.0&#160;mg/g <xref rid="bib11" ref-type="bibr">[11]</xref>. The compound has a variety of biological activities such as anti-microbes, anti-virus, oxidation prevention, anti-tumor and anti-hypertension <xref rid="bib12" ref-type="bibr">[12]</xref>.</p><p id="p0015">Several HPLC methods were developed for the pharmacokinetic studies of chlorogenic acid <xref rid="bib13" ref-type="bibr">[13]</xref>, <xref rid="bib14" ref-type="bibr">[14]</xref>, <xref rid="bib15" ref-type="bibr">[15]</xref>, <xref rid="bib16" ref-type="bibr">[16]</xref>, <xref rid="bib17" ref-type="bibr">[17]</xref>, <xref rid="bib18" ref-type="bibr">[18]</xref>. Ren et al. <xref rid="bib19" ref-type="bibr">[19]</xref> reported that the pharmacokinetic behavior of chlorogenic acid after oral administration has obvious difference among different dosages (200, 400 and 600&#160;mg/kg). It is well known that the contents of active ingredients in traditional Chinese medicine are usually low, so the studies of their pharmacokinetic behavior at small dose (50.0&#160;mg/kg) are important and necessary. In addition, other components in <italic toggle="yes">S. lyratum</italic> may change the pharmacokinetics of chlorogenic acid, and there was no report related to this issue.</p><p id="p0020">In this study, a reliable HPLC method was established to determine the concentration of chlorogenic acid in rat plasma. The pharmacokinetic behaviors between chlorogenic acid and extract of <italic toggle="yes">S. lyratum</italic> after oral administration were compared. It is important for understanding of the synergism of components among <italic toggle="yes">S. lyratum</italic> and designing rational dosage regimens.</p></sec><sec id="s0010"><label>2</label><title>Materials and methods</title><sec id="s0015"><label>2.1</label><title>Chemicals and reagents</title><p id="p0025">Chlorogenic acid (<xref rid="f0005" ref-type="fig">Fig. 1</xref>A) and the internal standard (IS), puerarin (<xref rid="f0005" ref-type="fig">Fig. 1</xref>B), were provided by the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). <italic toggle="yes">S. lyratum</italic> was purchased from Xuhui Pharmaceutical Co. Ltd. (Shanghai, China) and was genuinely identified by Prof. Qi-Shi Sun (Shenyang Pharmaceutical University, China). Methanol (HPLC grade) and other analytical grade reagents were obtained from Yuwang Reagent Company (Shenyang, China).<fig id="f0005" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Chemical structure of chlorogenic acid (A) and puerarin (B).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p></sec><sec id="s0020"><label>2.2</label><title>Instruments and chromatographic conditions</title><p id="p0030">The HPLC system consisted of a Shimadzu LC-10A pump, an SPD-10AV detector and a column oven. Data were processed using Anastar software (Autoscience Instrument Co. Ltd., China).</p><p id="p0035">The separation was performed on a Diamonsil-C<sub>18</sub> column (250&#160;mm&#215;4.6&#160;mm, 5&#160;&#956;m). The mobile phase was methanol&#8211;0.05% phosphoric acid (23:77, v/v) at a flow rate of 1&#160;mL/min. UV detector was set at 327&#160;nm and the column temperature was maintained at 30&#160;&#176;C. The sample injection volume was 20&#160;&#956;L.</p></sec><sec id="s0025"><label>2.3</label><title>Preparation of standards</title><p id="p0040">The working solution of chlorogenic acid was prepared at concentrations over 0.250&#8211;75.0&#160;mg/L in methanol. Quality control (QC) solutions were prepared at 0.50, 2.50, 60.0&#160;mg/L in the same way. Internal standard working solution of 5.00&#160;mg/L was prepared by dissolving the accurately weighed puerarin in methanol. All the solutions were stored at 4&#160;&#176;C away from light.</p><p id="p0045">The calibration standards were prepared by spiking 100&#160;&#956;L of blank plasma with 20&#160;&#956;L chlorogenic acid standard solution to obtain final serial concentrations of 0.0500, 0.100, 0.200, 0.500, 1.00, 2.00, 5.00 and 15.0&#160;mg/L. QC samples were prepared at concentrations of 0.100, 0.500 and 12.0&#160;mg/L in the same manner.</p></sec><sec id="s0030"><label>2.4</label><title><italic toggle="yes">S. lyratum</italic> extracts preparations</title><p id="p0050">The dried and crushed herbs of <italic toggle="yes">S. lyratum</italic> (400&#160;g) were extracted with 90% ethanol under refluxing three times for an hour per time. The crude extract obtained by vacuum concentration was subjected to absorbent resin (AB-8) column chromatography with a gradient of ethanol in water. The ratios of ethanol used during the procedure of column chromatography were 0, 20%, 40%, 60% and 90%, and initial eluant was water absolutely. LC with UV detector was used to monitor the elution process of chlorogenic acid. Chlorogenic acid (7.8&#160;g) was separated from fraction 1 (using water as elute) and fraction 2 (using 20% ethanol as elute). The content of chlorogenic acid in the extractive was 15.1&#160;mg/g detected by LC.</p></sec><sec id="s0035"><label>2.5</label><title>Plasma samples preparations</title><p id="p0055">Plasma samples (100&#160;&#956;L) were spiked with 20&#160;&#956;L puerarin (IS, 5.00&#160;mg/L) and were acidified by adding 10&#160;&#956;L hydrochloric acid (0.8&#160;mol/L). The mixture was extracted with 2&#160;mL isopropyl alcohol for 7&#160;min. After centrifuged at 12,000&#160;rpm for 5&#160;min, the supernatant was transferred to another tube and evaporated to dryness under a stream of nitrogen at 40&#160;&#176;C. The residue obtained was reconstituted in 50&#160;&#956;L mobile phase, 20&#160;&#956;L of which was injected into the HPLC system.</p></sec><sec id="s0040"><label>2.6</label><title>Method validation</title><p id="p0060">Blank rat plasma obtained from six different sources was processed and analyzed for the assessment of potential interferences with endogenous substances.</p><p id="p0065">Calibration curves were constructed over the concentration range of 0.0500&#8211;15.0&#160;mg/L by plotting the observed peak area ratios of chlorogenic acid and IS against known concentration of chlorogenic acid. The results were fitted to linear regression analysis using 1/<italic toggle="yes">x</italic><sup>2</sup> as weighting factor. The lower limit of quantification (LLOQ) was estimated using signal to noise ratio of 10.</p><p id="p0070">The precision and accuracy were assessed by determining QC samples at three concentration levels on three different days. The accuracy was expressed by relative error (RE) and the precision was defined as the relative standard deviation (RSD).</p><p id="p0075">The extraction recovery of chlorogenic acid at three QC levels was determined by comparing peak areas of chlorogenic acid with those obtained from direct injection of the corresponding standards dissolved in the supernatant of the processed blank plasma.</p><p id="p0080">The stability was evaluated by determining QC samples (0.100, 0.500 and 12.0&#160;mg/L) after storage at room temperature (25&#160;&#176;C) away from light for 24&#160;h.</p></sec><sec id="s0045"><label>2.7</label><title>Pharmacokinetic study in rats</title><p id="p0085">Male Wistar rats (240&#8211;260&#160;g) were supplied by the Experimental Animal Center of Shenyang Pharmaceutical University. They were kept under controlled conditions (room temperature 22&#177;2&#160;&#176;C, relative humidity 50&#177;20%) for three days before the experiment start. Before drug administration, they were fasted overnight and allowed free access to water. Animal experiments were carried out in accordance with the Guidelines for Animal Experimentation of Shenyang Pharmaceutical University (Shenyang, China) and the procedure was approved by the Animal Ethics Committee of this institution.</p><p id="p0090">Male Wistar rats were divided into two groups (six rats each group). The first group was given oral administration of chlorogenic acid at a dose of 50.0&#160;mg/kg while the second group was given 3.31&#160;g/kg extract of <italic toggle="yes">S. lyratum</italic> (equal to 50.0&#160;mg/kg chlorogenic acid) orally. Blood samples (0.3&#160;mL) were collected from the eye vein before (0&#160;h) and 0.17, 0.33, 0.50, 0.75, 1.0, 2.0, 4.0, 6.0 and 8.0&#160;h after administration into heparinized tubes. These samples were immediately centrifuged at 3000&#160;rpm for 10&#160;min, and the plasma obtained was stored at &#8722;20&#160;&#176;C until analysis.</p></sec><sec id="s0050"><label>2.8</label><title>Data analysis</title><p id="p0095">Pharmacokinetic parameters were evaluated using non-compartmental assessment using the drug and statistics software (DAS, version 2.0, Pharmacology Institute of China). The area under the plasma concentration&#8211;time curve from zero to the time of the last measurable sample (AUC<sub>0&#8722;<italic toggle="yes">t</italic></sub>) was calculated by the linear&#8211;trapezoidal method. The area under the plasma concentration&#8211;time curve from zero to infinity (AUC<sub>0&#8722;&#8734;</sub>) was estimated by means of the trapezoidal rule with extrapolation to infinity with apparent elimination rate constant (<italic toggle="yes">K</italic><sub><italic toggle="yes">e</italic></sub>). The <italic toggle="yes">K</italic><sub><italic toggle="yes">e</italic></sub> was estimated by log&#8211;linear regression of concentrations observed during the terminal phase of elimination, and the corresponding elimination half-life (<italic toggle="yes">t</italic><sub>1/2</sub>) was then calculated as 0.693/<italic toggle="yes">K</italic><sub><italic toggle="yes">e</italic></sub>. The maximum plasma concentration (<italic toggle="yes">C</italic><sub>max</sub>) and their time of occurrence (<italic toggle="yes">T</italic><sub>max</sub>) were obtained directly from the measured data. Pharmacokinetic parameters after oral administration of chlorogenic acid and extract of <italic toggle="yes">S. lyratum</italic> were expressed as mean&#177;SD and were compared by a two one-sided <italic toggle="yes">t</italic> test using the Statistical Package for the Social Science (SPSS, version 16.0). The significant difference was defined as <italic toggle="yes">P</italic>&lt;0.05.</p></sec></sec><sec id="s0055"><label>3</label><title>Results</title><sec id="s0060"><label>3.1</label><title>Method validation</title><p id="p0100">Typical chromatograms of blank plasma, blank plasma spiked with chlorogenic acid and IS, rat plasma sample 1&#160;h after oral administration of chlorogenic acid and rat plasma sample 1&#160;h after oral administration of extract of <italic toggle="yes">S. lyratum</italic> are presented in <xref rid="f0010" ref-type="fig">Fig. 2</xref>. The retention times for chlorogenic acid and IS were 18.5 and 31.7&#160;min, respectively. The biological matrix did not interfere with the determination of chlorogenic acid and IS.<fig id="f0010" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Chromatograms of chlorogenic acid in rat plasma. A: blank plasma; B: plasma spiked with chlorogenic acid (0.500&#160;mg/L) and puerarin (IS, 2.50&#160;mg/L); C: plasma sample 1&#160;h after oral administration of 50.0&#160;mg/kg chlorogenic acid; D: plasma sample 1&#160;h after oral administration of extract of <italic toggle="yes">S. lyratum.</italic> Peak 1, chlorogenic acid (18.5&#160;min). Peak 2, puerarin (31.7&#160;min).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig></p><p id="p0105">The calibration curve of chlorogenic acid was linear in the range of 0.0500&#8211;15.0&#160;mg/L with a mean correlation coefficient (<italic toggle="yes">r</italic>) (<italic toggle="yes">n</italic>=3) of 0.9982, a slope of 2.025 and an intercept of 4.498&#215;10<sup>&#8722;2</sup>. The LLOQ obtained for the analyte was 0.0500 mg/L, with the RSD and RE of 7.6% and 9.1%, respectively.</p><p id="p0110">The intra-day and inter-day precisions of chlorogenic acid at low to high concentrations were better than 1.8% and 8.6%, respectively. The accuracy (RE) of chlorogenic acid ranged from &#8722;6.8% to &#8722;1.8%. The results indicated that the reproducibility of the method was acceptable.</p><p id="p0115">The mean extraction recovery (<italic toggle="yes">n</italic>=5) at three concentration levels was 68.6%, 71.8% and 72.9%, and RSD was 7.2%, 4.2% and 5.1%. Mean recovery of the IS was 90.5% with the RSD of 4.6% (<italic toggle="yes">n</italic>=15).</p><p id="p0120">Stability of chlorogenic acid in prepared samples at room temperature (25&#176;C) away from light for 24&#160;h was determined by QC samples (<italic toggle="yes">n</italic>=5) at three concentration levels. RE of the three concentration levels was &#8722;3.6%, 5.3% and &#8722;8.5%, respectively.</p></sec><sec id="s0065"><label>3.2</label><title>Pharmacokinetics study</title><p id="p0125">Comparative pharmacokinetics of chlorogenic acid was performed after oral administration of 50.0&#160;mg/kg of chlorogenic acid or extract of <italic toggle="yes">S. lyratum</italic> (equal to 50.0&#160;mg/kg chlorogenic acid) to rats. Pharmacokinetic parameters were obtained using non-compartmental methods. The mean plasma concentration&#8211;time curve profiles are illustrated in <xref rid="f0015" ref-type="fig">Fig. 3</xref> and their pharmacokinetic parameters are listed in <xref rid="t0005" ref-type="table">Table 1</xref>. Pharmacokinetic parameters after oral administration of chlorogenic acid and extract of <italic toggle="yes">S. lyratum</italic> were compared by two one-sided <italic toggle="yes">t</italic> test using SPSS program (version 16.0). The AUC<sub>0&#8722;<italic toggle="yes">t</italic></sub> and AUC<sub>0&#8722;&#8734;</sub> for extract of <italic toggle="yes">S. lyratum</italic> were 0.76&#177;0.26 and 0.83&#177;0.27&#160;mg&#160;h/L, and were significantly lower than those obtained after administration of chlorogenic acid. The clearance (CLz/F) for extract of <italic toggle="yes">S. lyratum</italic> was 65&#177;21&#160;L/(kg&#160;h), which was significantly higher than that after administration of pure chlorogenic acid.<fig id="f0015" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Plasma concentration versus time profiles of chlorogenic acid in rats (<italic toggle="yes">n</italic>=6) after oral administration.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr3.jpg"/></fig><table-wrap id="t0005" position="float" orientation="portrait"><label>Table 1</label><caption><p>Pharmacokinetic parameters after oral administration of chlorogenic acid (50.0&#160;mg/kg) and extract of <italic toggle="yes">S. lyratum</italic> (equal to 50.0&#160;mg/kg chlorogenic acid) (<italic toggle="yes">n</italic>=6/group).</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Parameters</th><th colspan="1" rowspan="1">Chlorogenic acid (P.O.)</th><th colspan="1" rowspan="1">Extract of <italic toggle="yes">S. lyratum</italic> (P.O.)</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">AUC<sub>0&#8722;<italic toggle="yes">t</italic></sub> (mg&#160;h/L)</td><td align="char" colspan="1" rowspan="1">1.50&#177;0.91</td><td align="char" colspan="1" rowspan="1">0.76&#177;0.26<xref rid="tbl1fnStar" ref-type="table-fn">*</xref></td></tr><tr><td colspan="1" rowspan="1">AUC<sub>0&#8722;&#8734;</sub> (mg&#160;h/L)</td><td align="char" colspan="1" rowspan="1">1.61&#177;0.92</td><td align="char" colspan="1" rowspan="1">0.83&#177;0.27<xref rid="tbl1fnStar" ref-type="table-fn">*</xref></td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">t</italic><sub>1/2</sub> (h)</td><td align="char" colspan="1" rowspan="1">1.70&#177;0.24</td><td align="char" colspan="1" rowspan="1">1.7&#177;0.2</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">T</italic><sub>max</sub> (h)</td><td align="char" colspan="1" rowspan="1">0.48&#177;0.29</td><td align="char" colspan="1" rowspan="1">0.36&#177;0.07</td></tr><tr><td colspan="1" rowspan="1">CLz/F [L/(h&#160;kg)]</td><td align="char" colspan="1" rowspan="1">39&#177;17</td><td align="char" colspan="1" rowspan="1">65&#177;21<xref rid="tbl1fnStar" ref-type="table-fn">*</xref></td></tr><tr><td colspan="1" rowspan="1">Vz/F (L/kg)</td><td align="char" colspan="1" rowspan="1">97.5&#177;47</td><td align="char" colspan="1" rowspan="1">154&#177;33</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">C</italic><sub>max</sub> (mg/L)</td><td align="char" colspan="1" rowspan="1">0.55&#177;0.22</td><td align="char" colspan="1" rowspan="1">0.37&#177;0.12</td></tr><tr><td colspan="1" rowspan="1"><italic toggle="yes">K</italic><sub><italic toggle="yes">e</italic></sub> (1/h)</td><td align="char" colspan="1" rowspan="1">0.41&#177;0.06</td><td align="char" colspan="1" rowspan="1">0.41&#177;0.19</td></tr></tbody></table><table-wrap-foot><fn id="tbl1fnStar"><label>*</label><p>Represent significant difference or <italic toggle="yes">P</italic>&lt;0.05.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec id="s0070"><label>4</label><title>Discussion</title><sec id="s0075"><label>4.1</label><title>Optimization of plasma samples preparations</title><p id="p0130">Reagents like methanol, acetonitrile and perchloric acid were tested for protein precipitation; however, the recovery of chlorogenic acid was low. Chlorogenic acid was a biprotic acid with p<italic toggle="yes">K</italic><sub><italic toggle="yes">a</italic>1</sub>=3.59, p<italic toggle="yes">K</italic><sub><italic toggle="yes">a</italic>2</sub>=8.59, and was difficult to extract by liquid&#8211;liquid extraction in nearly neutral environment. So variety of concentrations (0.4, 0.6, 0.8, 1.0, 1.2&#160;mol/L) of hydrochloric acid (10&#160;&#956;L) were tried to adjust pH of plasma samples. The results indicated that recovery of chlorogenic acid obviously increased with concentrations of hydrochloric acid until 0.8&#160;mol/L, and endogenous interference increased significantly when concentration of hydrochloric acid was higher than 0.8&#160;mol/L. Therefore, 10&#160;&#956;L of hydrochloric acid (0.8&#160;mol/L) was added to plasma samples during sample preparation. Ethyl acetate, ethyl acetate&#8211;isopropanol (10:90, v/v) and isopropanol were tested as extract solvent for chlorogenic acid extraction from plasma samples. Isopropanol gave the highest recovery of chlorogenic acid, and was finally chosen as the extraction solvent.</p></sec><sec id="s0080"><label>4.2</label><title>Pharmacokinetic study</title><p id="p0135">The current HPLC method was developed and validated for the determination of chlorogenic acid in rat plasma. The pharmacokinetics of chlorogenic acid after oral administration of pure chlorogenic acid and extract of <italic toggle="yes">S. lyratum</italic> was compared. The main differences between the pharmacokinetic data of the two groups reflected in the AUC<sub>0&#8722;<italic toggle="yes">t</italic></sub>, AUC<sub>0&#8722;&#8734;</sub> and CLz/F, suggesting that other compounds in <italic toggle="yes">S. lyratum</italic> may prohibit the absorption of chlorogenic acid and accelerate the elimination of chlorogenic acid in rats. This phenomenon was reported for the first time, and further investigation is already in progress.</p><p id="p0140">In addition, a second absorption peak appeared about 1 h after oral administration in both of the two plasma concentration&#8211;time curves, it may be caused by the reabsorption of hepatoenteral circulation. This phenomenon has not been reported before.</p><p id="p0145">The major part of chlorogenic acid was not absorbed in the proximal part of the gut and reached the large intestine where it was hydrolyzed by the microflora <xref rid="bib20" ref-type="bibr">[20]</xref>, <xref rid="bib21" ref-type="bibr">[21]</xref>. Most of chlorogenic acid was metabolized easily in intestine. The main metabolites were benzoic acid, benzene propanoic acid and cinnamic acid <xref rid="bib22" ref-type="bibr">[22]</xref>. The information about the absorption and metabolism of chlorogenic acid may relate to the reabsorption of hepatoenteral circulation. Moreover, some other components of <italic toggle="yes">S. lyratum</italic> in intestine could restrain the absorption of chlorogenic acid.</p></sec></sec><sec id="s0085"><label>5</label><title>Conclusion</title><p id="p0150">In conclusion, pharmacokinetic behaviors of chlorogenic acid after oral dosing of chlorogenic acid and extract of <italic toggle="yes">S. lyratum</italic> had significant differences. The absorption and excretion of chlorogenic acid can be inhibited by the interaction between other components of <italic toggle="yes">S. lyratum</italic>. These conclusions could provide references for further studies on developing new dosage forms of <italic toggle="yes">S. lyratum</italic>. The results also confirmed the theory that monomeric compound was unable to represent the whole herb on the pharmacokinetic study of traditional Chinese medicine. To get reliable and accurate results, traditional Chinese medicine should be investigated as a whole.</p></sec></body><back><ref-list id="bibliog0005"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sbref108"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>E.</given-names></name></person-group><article-title>The nitric oxide-producing properties of <italic toggle="yes">Solanum Lyratum</italic></article-title><source>J. Ethnopharmacol.</source><volume>67</volume><year>1999</year><fpage>163</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">10619380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-8741(99)00011-2</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sbref109"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>I.</given-names></name></person-group><article-title>Abolition of anaphylactic shock by <italic toggle="yes">Solanum lyratum</italic> Thunb.</article-title><source>Int. J. Immunopharmacol.</source><volume>19</volume><issue>11/12</issue><year>1997</year><fpage>729</fpage><lpage>734</lpage><pub-id pub-id-type="pmid">9669214</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0192-0561(97)00035-0</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sbref110"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>E.J.</given-names></name></person-group><article-title><italic toggle="yes">Solanum lyratum</italic> inhibits anaphylactic reaction and suppresses the expression of <sc>l</sc>-histidine decarboxylase mRNA</article-title><source>Immunopharm. Immunol.</source><volume>20</volume><issue>1</issue><year>1998</year><fpage>135</fpage><lpage>146</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/08923979809034813</pub-id><pub-id pub-id-type="pmid">9543704</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sbref111"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>S.Y.</given-names></name><name name-style="western"><surname>Sang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Park</surname><given-names>J.H.</given-names></name></person-group><article-title>Hepatoprotective activity of scopoletin, a constituent of <italic toggle="yes">Solanum lyratum</italic></article-title><source>Arch. Pharm. Res.</source><volume>21</volume><issue>6</issue><year>1998</year><fpage>7l8</fpage><lpage>722</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF02976764</pub-id><pub-id pub-id-type="pmid">9868544</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sbref112"><person-group person-group-type="author"><name name-style="western"><surname>Kuo</surname><given-names>K.W.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.P.</given-names></name></person-group><article-title>Anticancer activity evaluation of the <italic toggle="yes">Solanum</italic> glycoalkaloid solamargine</article-title><source>Biochem. Pharmacol.</source><volume>60</volume><year>2000</year><fpage>1865</fpage><lpage>1873</lpage><pub-id pub-id-type="pmid">11108802</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0006-2952(00)00506-2</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sbref113"><person-group person-group-type="author"><name name-style="western"><surname>Murakami</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ezima</surname><given-names>H.</given-names></name></person-group><article-title>Studies on the constituents of Solanum plants. V. The constituents of <italic toggle="yes">S. lyratum</italic> Thunb. II</article-title><source>Chem. Pharm. Bull.</source><volume>33</volume><issue>1</issue><year>1985</year><fpage>67</fpage><lpage>73</lpage></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sbref114"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>L.X.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>W.W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>W.</given-names></name></person-group><article-title>Diosgenin glucuronides from <italic toggle="yes">Solanum lyratum</italic> and their cytotoxicity against tumor cell lines</article-title><source>Z. Naturforsch. C: Biosci.</source><volume>61c</volume><year>2006</year><fpage>171</fpage><lpage>176</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/znc-2006-3-403</pub-id><pub-id pub-id-type="pmid">16729572</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sbref115"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>L.X.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>W.W.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>J.</given-names></name></person-group><article-title>Cytotoxic constituents from <italic toggle="yes">Solanum Lyratum</italic></article-title><source>Arch. Pharm. Res.</source><volume>29</volume><issue>2</issue><year>2006</year><fpage>135</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">16526277</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF02974274</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sbref116"><person-group person-group-type="author"><name name-style="western"><surname>Murakami</surname><given-names>K.</given-names></name><name name-style="western"><surname>Saijo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nohara</surname><given-names>T.</given-names></name></person-group><article-title>Studies on the constituents of Solanum plants. I. On the constituents of the stem parts of <italic toggle="yes">Solanum lyratum</italic> THUNB</article-title><source>Yakugaku Zasshi</source><volume>101</volume><issue>3</issue><year>1981</year><fpage>275</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">7299640</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1248/yakushi1947.101.3_275</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sbref117"><person-group person-group-type="author"><name name-style="western"><surname>Yahara</surname><given-names>S.</given-names></name><name name-style="western"><surname>Morooka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>M.</given-names></name></person-group><article-title>Two new steroidal glucuronides from <italic toggle="yes">Solanum lyratum</italic> II</article-title><source>Planta. Med.</source><volume>6</volume><issue>12</issue><year>1986</year><fpage>496</fpage><lpage>498</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-2007-969267</pub-id><pub-id pub-id-type="pmid">17345422</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sbref118"><person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L.X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H.X.</given-names></name></person-group><article-title>Simultaneous determination of chlorogenic acid and caffeic acid in <italic toggle="yes">Solanum lyratum</italic> Thunb</article-title><source>J. Shenyang Pharm. Univ.</source><volume>26</volume><issue>6</issue><year>2009</year><fpage>451</fpage><lpage>455</lpage><comment>(in Chinese)</comment></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sbref119"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ouyang</surname><given-names>D.S.</given-names></name></person-group><article-title>Progresses in the pharmacology of chlorogenic acid</article-title><source>Nat. Prod. Res. Dev.</source><volume>18</volume><issue>4</issue><year>2006</year><fpage>691</fpage><lpage>694</lpage><comment>(in Chinese)</comment></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sbref120"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.P.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J.Y.</given-names></name></person-group><article-title>Determination and pharmacokinetic study of chlorogenic acid in rat dosed with Yin-Huang granules by RP-HPLC</article-title><source>Biomed. Chromatogr.</source><volume>20</volume><issue>2</issue><year>2006</year><fpage>206</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">16110471</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/bmc.555</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sbref121"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>Q.F.</given-names></name><name name-style="western"><surname>Jia</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Q.T.</given-names></name></person-group><article-title>High-performance liquid chromatographic method for determination and pharmacokinetic study of chlorogenic acid in the plasma of rats after administration of the Chinese medicinal preparation Luying decoction</article-title><source>Chromatographia</source><volume>62</volume><issue>1&#8211;2</issue><year>2005</year><fpage>103</fpage><lpage>107</lpage></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sbref122"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.F.</given-names></name><name name-style="western"><surname>Shum</surname><given-names>A.Y.C.</given-names></name></person-group><article-title>Determination of chlorogenic acid in rat blood by microdialysis coupled with microbore liquid chromatography in pharmacokinetic application</article-title><source>J. Chromatogr. A</source><volume>870</volume><issue>1&#8211;2</issue><year>2000</year><fpage>443</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">10722100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0021-9673(99)01153-x</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sbref123"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Jun</surname><given-names>X.D.</given-names></name></person-group><article-title>Pharmacokinetic study on chlorogenic acid</article-title><source>Chin. Trad. Pat. Med.</source><volume>21</volume><issue>4</issue><year>1999</year><fpage>161</fpage><lpage>162</lpage><comment>(in Chinese)</comment></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sbref124"><person-group person-group-type="author"><name name-style="western"><surname>Rong</surname><given-names>G.</given-names></name><name name-style="western"><surname>Qiang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>G.</given-names></name></person-group><article-title>Gradient high-performance liquid chromatography for the simultaneous determination of chlorogenic acid and baicalin in plasma and its application in the study of pharmacokinetics in rats</article-title><source>J. Pharm. Biomed. Anal.</source><volume>43</volume><issue>1</issue><year>2007</year><fpage>335</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">16859859</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpba.2006.06.020</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sbref125"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>X.</given-names></name></person-group><article-title>Study on determination method and pharmaeokineties of chlorogenic acid in animals after mainline</article-title><source>Sichuan Univ., Chengdu, China</source><year>2005</year><fpage>28</fpage><lpage>31</lpage><comment>(in Chinese)</comment></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sbref126"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X.H.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.R.</given-names></name></person-group><article-title>Investigation on the absorption kinetics of chlorogenic acid in rats by HPLC</article-title><source>Arch. Pharm. Res.</source><volume>30</volume><issue>7</issue><year>2007</year><fpage>911</fpage><lpage>916</lpage><pub-id pub-id-type="pmid">17703746</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF02978845</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sbref127"><person-group person-group-type="author"><name name-style="western"><surname>Plumb</surname><given-names>G.W.</given-names></name><name name-style="western"><surname>Garcia-Conesa</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Kroon</surname><given-names>P.A.</given-names></name></person-group><article-title>Metabolism of chlorogenic acid by human plasma, liver, intestine and gut microflora</article-title><source>J. Sci. Food Agric.</source><volume>79</volume><issue>3</issue><year>1999</year><fpage>390</fpage><lpage>392</lpage></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sbref128"><person-group person-group-type="author"><name name-style="western"><surname>Couteau</surname><given-names>D.</given-names></name><name name-style="western"><surname>McCartney</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>G.R.</given-names></name></person-group><article-title>Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid</article-title><source>J. Appl. Microbiol.</source><volume>90</volume><year>2001</year><fpage>873</fpage><lpage>881</lpage><pub-id pub-id-type="pmid">11412317</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-2672.2001.01316.x</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sbref129"><person-group person-group-type="author"><name name-style="western"><surname>Gonthier</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Verny</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Besson</surname><given-names>C.</given-names></name></person-group><article-title>Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats</article-title><source>J. Nutr.</source><volume>133</volume><issue>6</issue><year>2003</year><fpage>1853</fpage><lpage>1859</lpage><pub-id pub-id-type="pmid">12771329</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jn/133.6.1853</pub-id></element-citation></ref></ref-list><ack><title>Acknowledgments</title><p>The study was supported by the <funding-source id="gs1">Science and Technology Bureau of Liaoning Province</funding-source> (No. 2007226011) and the <funding-source id="gs2">Shenyang Technology Bureau</funding-source> (No. 1071164-9-00).</p></ack></back></article></pmc-articleset>